The results demonstrated that the relative expression of LCN2 and DEFA4 in COVID‐19 patients was significantly downregulated (logFC: −2.9, −5.35, respectively) compared with healthy individuals (Figure 5A,B). This evidence concerns the gene LCN2 and COVID-19.